The 14th international conference on cachexia and sarcopenia to be hosted digitally on December 11-12, 2021.
With increasing uncertainties around variants of the COVID-19 virus, the SCWD Board has made the decision to cancel plans for the in-person component of 14th international conference on cachexia and sarcopenia in Ljubjana, Slovenia. As medical professionals, it is imperative that we put the health and safety of our participants first, and developments surrounding the virus and its variants have raised significant concerns about safely bringing a large group of people together.
On December 11-12 2021, we will present highlights of 2021 from a point of view of basic science and clinical science. Online access on our secure interactive platform will be free for all SCWD members.
Scientific Programme is available here
Scientific Programme is available here
We remain committed to delivering the leaders in education and research regarding cachexia, sarcopenia and muscle wasting.
We are therefore glad to announce that the 15th international conference on cachexia and sarcopenia will take place in Lisbon, Portugal, on July 1-3, 2022. It will be an excellent forum to discuss in-person the latest research and findings in cachexia, sarcopenia and muscle wasting.
While we are all disappointed not to have the opportunity to meet in-person, we remain hopeful that we will soon see the end of this pandemic and will be able to meet safely again in July 2022 in Lisbon.
Thank you for your understanding. We look forward to seeing you – safely – online in December!
Sincerely,
The SCWD Board
This year, the 14th international SCWD Conference on Cachexia, Sarcopenia and Muscle Wasting is held with support of Charité University.
Society Activities
Recent Projects include:
• International conferences
• Consensus workshops
• The Journal of Cachexia, Sarcopenia and Muscle (JCSM)
More on the SCWD society >
Latest Pubmed “Cachexia” article feed
- Cachexia - A Cluster of Losses
- Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ()Tablets), the first orally available drug for cancer cachexia with ghrelin-like action in Japan
- Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
- Tumours block protective muscle and nerve signals to cause cachexia
- Shared and distinct mechanisms of skeletal muscle atrophy: A narrative review
- IGF-1 and IGFBP-3 in Inflammatory Cachexia
- Cancer Cachexia: Its Mechanism and Clinical Significance
- Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs
- Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis
- Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
Cachexia, Sarcopenia and Muscle Wasting: Definition
INTERVIEWS
Dr A Schols – towards a multi-modal intervention strategy in cachexia treatment
Dr John Morley discuses recent sarcopenia definitions
Prof Muscaritoli on the Premio study and cachexia prevalence in patients with cancer
Join the Society
Member benefits:
• Conference Powerpoints
• Registration reductions
• Networking …
Become a member >
14th annual conference
View details
About the SCWD society
Research and education in cachexia, …
Become a member of SCWD
Apply for SCWD membership
Overview of wasting disorders
SCWD articles on:
Cachexia >
Sarcopenia >
Muscle wasting >
Definitions of cachexia and sarcopenia
View recent definitions from the literature together with videos on how to define cachexia and sarcopenia.